(18)F-FDG PET-CT for Surveillance of Brazilian Patients with Li-Fraumeni Syndrome.

Autor: Nogueira ST; Oncogenetics, AC Camargo Cancer Center , São Paulo , Brazil., Lima EN; Nuclear Medicine, AC Camargo Cancer Center , São Paulo , Brazil., Nóbrega AF; Oncogenetics, AC Camargo Cancer Center , São Paulo , Brazil., Torres Ido C; Nuclear Medicine, AC Camargo Cancer Center , São Paulo , Brazil., Cavicchioli M; Nuclear Medicine, AC Camargo Cancer Center , São Paulo , Brazil., Hainaut P; International Prevention Research Institute (iPRI) , Lyon , France., Achatz MI; Oncogenetics, AC Camargo Cancer Center , São Paulo , Brazil.

Publikováno v: Frontiers in oncology [Front Oncol] 2015 Feb 19; Vol. 5, pp. 38. Date of Electronic Publication: 2015 Feb 19 (Print Publication: 2015).

Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.

Autor: Bojadzieva, Jasmina, Amini, Behrang, Day, Suzanne F., Jackson, Tiffiny L., Thomas, Parijatham S., Willis, Brandy J., Throckmorton, Whitney R., Daw, Najat C., Bevers, Therese B., Strong, Louise C.

Publikováno v: Familial Cancer; Apr2018, Vol. 17 Issue 2, p287-294, 8p